Indication

Hemangiomata of infancy

Hemangiomata of infancy (commonly termed infantile hemangiomas) are benign vascular neoplasms characterized by the abnormal proliferation of endothelial cells. Read more about Hemangiomata of infancy

1 drugs 1 manufacturers

Drugs that treat it

Common Hemangiomata of infancy therapies.

Showing 1–1 of 1 drugs

Sort

HEMANGEOL (propranolol HCl)

BETA-BLOCKERS (SYSTEMIC)·HEMANGIOMATA OF INFANCY

ETON PHARMACEUT

Filter & compare in the drug finder →Opens the drug finder with Hemangiomata of infancy preselected.

News & literature

Coming soon

Related codes

Coming soon

About Hemangiomata of infancy.

Hemangiomata of infancy (commonly termed infantile hemangiomas) are benign vascular neoplasms characterized by the abnormal proliferation of endothelial cells.

Arising primarily in infants during the first few weeks of life, they most frequently involve the cutaneous and subcutaneous tissues of the head and neck, though they may also affect visceral organs such as the liver.

Clinically, these lesions follow a distinct natural history comprising an early phase of rapid proliferation during early infancy followed by a plateau and eventual gradual involution over several years.

While many run a self-limited and uncomplicated course, high-risk lesions can lead to complications such as ulceration, bleeding, permanent disfigurement, or the impairment of vital physiological functions.

nih.gov
Hemangiomata of infancy (commonly termed infantile hemangiomas) are benign vascular neoplasms characterized by the abnormal proliferation of endothelial cells
cincinnatichildrens.org
Hemangiomata of infancy (commonly termed infantile hemangiomas) are benign vascular neoplasms characterized by the abnormal proliferation of endothelial cells
nih.gov
Arising primarily in infants during the first few weeks of life, they most frequently involve the cutaneous and subcutaneous tissues of the head and neck, though they may also affect visceral organs such as the liver While many run a self-limited and uncomplicated course, high-risk lesions can lead to complications such as ulceration, bleeding, permanent disfigurement, or the impairment of vital physiological functions
chop.edu
Arising primarily in infants during the first few weeks of life, they most frequently involve the cutaneous and subcutaneous tissues of the head and neck, though they may also affect visceral organs such as the liver
dermnetnz.org
Arising primarily in infants during the first few weeks of life, they most frequently involve the cutaneous and subcutaneous tissues of the head and neck, though they may also affect visceral organs such as the liver
nih.gov
Clinically, these lesions follow a distinct natural history comprising an early phase of rapid proliferation during early infancy followed by a plateau and eventual gradual involution over several years
jci.org
Clinically, these lesions follow a distinct natural history comprising an early phase of rapid proliferation during early infancy followed by a plateau and eventual gradual involution over several years While many run a self-limited and uncomplicated course, high-risk lesions can lead to complications such as ulceration, bleeding, permanent disfigurement, or the impairment of vital physiological functions
nih.gov
While many run a self-limited and uncomplicated course, high-risk lesions can lead to complications such as ulceration, bleeding, permanent disfigurement, or the impairment of vital physiological functions

Personalize your experience

Follow Hemangiomata of infancy and get updates as they land.

Create a free account

Already a member? Sign in

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it